Literature DB >> 17637496

Injured microenvironment directly guides the differentiation of engrafted Flk-1(+) mesenchymal stem cell in lung.

Xi Yan1, Yanning Liu, Qin Han, Mingyue Jia, Lianming Liao, Maili Qi, Robert Chunhua Zhao.   

Abstract

OBJECTIVE: Time window is a key factor in the treatment of lung injury by mesenchymal stem cells (MSC) transplantation. This study was aimed to analyze the engraftment and differentiation behavior of MSC transplanted at different time points after lung irradiation, and the possible mechanisms were discussed.
MATERIALS AND METHODS: The thorax of C57BL/6 mice was exposed to 1400 cGy, then Flk-1(+)MSCs from enhanced green fluorescent protein C57BL/6 mice were systemically injected into C57BL/6 mice at 4 hours, 60 days, and 120 days post thoracic exposure, respectively. The engraftment and differentiation of Flk-1(+)MSC transplanted at different time points were evaluated. Lung tissue was collected and analyzed for fibrosis. Expression of transforming growth factor (TGF)-beta1 in the lung was qualified by semi-quantitative real-time reverse transcription polymerase chain reaction. In vitro, Flk-1(+)MSCs were cultured in epithelium induction media, together with damaged primary lung cells, supernatants of radiation-injured lung cells, or TGF-beta1 to find the possible factors that might effect Flk-1(+)MSC differentiation.
RESULTS: Cells injected immediately after injury were shown to differentiate into functional lung cells, such as epithelial and endothelial cells. Cells injected 2 months later were mostly located in the interstitial area and appeared as myofibrocyte. The in vivo lung microenvironments at different time points after injury were different from each other, especially TGF-beta1 expression. We demonstrated that cytokines secreted by irradiated lung cells could inhibit differentiation of Flk-1(+)MSCs into epithelial cells in vitro.
CONCLUSIONS: Flk-1(+)MSCs injected into the lung immediately after irradiation could differentiate into functional lung cells, while those injected at later stage after irradiation would be involved in fibrosis development. Thus our in vivo and in vitro studies demonstrated that differentiation of Flk-1(+)MSCs is controlled by the microenvironment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17637496     DOI: 10.1016/j.exphem.2007.05.012

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  42 in total

Review 1.  Mesenchymal stem cells hold promise for regenerative medicine.

Authors:  Shihua Wang; Xuebin Qu; Robert Chunhua Zhao
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

Review 2.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

Review 3.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

4.  Cell therapy trials for lung diseases: progress and cautions.

Authors:  Daniel J Weiss; Luis A Ortiz
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

5.  miRNA-146a expression positively regulates tumor necrosis factor-α-induced interleukin-8 production in mesenchymal stem cells and differentiated lung epithelial-like cells.

Authors:  Diahn-warng Perng; De-ming Yang; Yi-han Hsiao; Ting Lo; Oscar Kuang-sheng Lee; Mo-tzu Wu; Yu-chung Wu; Yu-chin Lee
Journal:  Tissue Eng Part A       Date:  2012-09-24       Impact factor: 3.845

6.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

7.  ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.

Authors:  Shennea Marriott; Rubin S Baskir; Christa Gaskill; Swapna Menon; Erica J Carrier; Janice Williams; Megha Talati; Karen Helm; Catherine E Alford; Jonathan A Kropski; James Loyd; Lisa Wheeler; Joyce Johnson; Eric Austin; Eva Nozik-Grayck; Barbara Meyrick; James D West; Dwight J Klemm; Susan M Majka
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-15       Impact factor: 4.249

Review 8.  Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.

Authors:  Marek Barczyk; Matthias Schmidt; Sabrina Mattoli
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

9.  Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis.

Authors:  Boris Hinz
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

10.  Oleanolic acid and ursolic acid inhibit proliferation in transformed rat hepatic oval cells.

Authors:  Yu-Ying Han; Xiao-Wei Xue; Zheng-Ming Shi; Peng-Yan Wang; Xin-Rui Wu; Xue-Jiang Wang
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.